| mRNA |
staurosporine |
CTRPv2 |
pan-cancer |
AAC |
0.34 |
1e-05 |
| mRNA |
isoliquiritigenin |
CTRPv2 |
pan-cancer |
AAC |
0.3 |
5e-05 |
| mRNA |
RAF265 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0005 |
| mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0006 |
| mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
| mRNA |
cimetidine |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
0.002 |
| mRNA |
quizartinib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.003 |